Individual Differences in the Disposition of Drugs Metabolised in the Body

Overview

Journal Clin Pharmacokinet

Specialty Pharmacology

Date 1978 Mar 1

PMID 346288

Citations 20

Authors

G Alvan

Affiliations

Soon will be listed here.

Citing Articles

Intra- and inter-subject variabilities of CGP 33101 after replicate single oral doses of two 200-mg tablets and 400-mg suspension.

Cheung W, Kianifard F, Wong A, Mathieu J, Cook T, John V Pharm Res. 1995; 12(12):1878-82.

PMID: 8786960 DOI: 10.1023/a:1016275402723.

Individual variation in first-pass metabolism.

Tam Y Clin Pharmacokinet. 1993; 25(4):300-28.

PMID: 8261714 DOI: 10.2165/00003088-199325040-00005.

Population pharmacokinetics of nortriptyline during monotherapy and during concomitant treatment with drugs that inhibit CYP2D6--an evaluation with the nonparametric maximum likelihood method.

Jerling M, Merle Y, Mentre F, Mallet A Br J Clin Pharmacol. 1994; 38(5):453-62.

PMID: 7893588 PMC: 1364880. DOI: 10.1111/j.1365-2125.1994.tb04382.x.

Wide variation in serum chlorpropamide concentration in outpatients.

Bergman U, Christenson I, Jansson B, Ostman Eur J Clin Pharmacol. 1980; 18(2):165-9.

PMID: 7428798 DOI: 10.1007/BF00561585.

Irregular drug intake and serum chlorpropaminde concentrations.

Eur J Clin Pharmacol. 1980; 18(2):159-63.

PMID: 7428797 DOI: 10.1007/BF00561584.

References

Perrier D, Gibaldi M . Clearance and biologic half-life as indices of intrinsic hepatic metabolism. J Pharmacol Exp Ther. 1974; 191(1):17-24. View

Ekstrand J, Alvan G, BOREUS L, Norlin A . Pharmacokinetics of fluoride in man after single and multiple oral doses. Eur J Clin Pharmacol. 1977; 12(4):311-7. DOI: 10.1007/BF00607432. View

Melander A, Danielson K, SCHERSTEN B, Wahlin E . Enhancement of the bioavailability of propranolol and metoprolol by food. Clin Pharmacol Ther. 1977; 22(1):108-12. DOI: 10.1002/cpt1977221108. View

Andersson K, Bergdahl B, Wettrell G . Biliary excretion and enterochepatic recycling of proscillaridin A after oral adminstration to man. Eur J Clin Pharmacol. 1977; 11(4):273-6. DOI: 10.1007/BF00607676. View

BEERMANN B, Hellstrom K, Rosen A . The absorption of orally administered (12 - 3 H)digoxin in man. Clin Sci. 1972; 43(4):507-18. DOI: 10.1042/cs0430507. View

DUGGAN D, Hooke K, NOLL R, Kwan K . Enterohepatic circulation of indomethacin and its role in intestinal irritation. Biochem Pharmacol. 1975; 24(19):1749-54. DOI: 10.1016/0006-2952(75)90450-5. View

BEERMANN B, Hellstrom K, Rosen A . Fate of orally administered 3H-digitoxin in man with special reference to the absorption. Circulation. 1971; 43(6):852-61. DOI: 10.1161/01.cir.43.6.852. View

Odar-Cederlof I, Lunde P, Sjoqvist F . Abnormal pharmacokinetics of phenytoin in a patient with uraemia. Lancet. 1970; 2(7677):831-2. DOI: 10.1016/s0140-6736(70)91506-0. View

Jenne J, Wyze M, Rood F, Macdonald F . Pharmacokinetics of theophylline. Application to adjustment of the clinical dose of aminophylline. Clin Pharmacol Ther. 1972; 13(3):349-60. DOI: 10.1002/cpt1972133349. View

10.

Spiker D, Biggs J . Tricyclic antidepressants. Prolonged plasma levels after overdose. JAMA. 1976; 236(15):1711-2. DOI: 10.1001/jama.236.15.1711. View

11.

Harris P, RIEGELMAN S . Influence of the route of administration on the area under the plasma concentration-time curve. J Pharm Sci. 1969; 58(1):71-5. DOI: 10.1002/jps.2600580114. View

12.

OKITA G, Talso P, CURRY Jr J, SMITH Jr F, Geiling E . Metabolic fate of radioactive digitoxin in human subjects. J Pharmacol Exp Ther. 1955; 115(4):371-9. View

13.

SHAND D, Cotham R, Wilkinson G . Perfusion-limited of plasma drug binding on hepatic drug extraction. Life Sci. 1976; 19(1):125-30. DOI: 10.1016/0024-3205(76)90382-9. View

14.

Reidenberg M, Odar-Cederlof I, von Bahr C, Borga O, Sjoqvist F . Protein binding of diphenylhydantoin and desmethylimipramine in plasma from patients with poor renal function. N Engl J Med. 1971; 285(5):264-7. DOI: 10.1056/NEJM197107292850506. View

15.

Gugler R, Shoeman D, Huffman D, Cohlmia J, AZARNOFF D . Pharmacokinetics of drugs in patients with the nephrotic syndrome. J Clin Invest. 1975; 55(6):1182-9. PMC: 301871. DOI: 10.1172/JCI108035. View

16.

Alvan G, Jonsson M, Sundwall A, Vessman J . First pass conjugation and enterohepatic recycling of oxazepam in dogs; intravenous tolerance of oxazepam in propylene glycol. Acta Pharmacol Toxicol (Copenh). 1977; 40 Suppl 1(1):16-27. View

17.

Alvan G, Lind M, Mellstrom B, von Bahr C . Importance of "first-pass elimination" for interindividual differences in steady-state concentrations of the adrenergic beta-receptor antagonist alprenolol. J Pharmacokinet Biopharm. 1977; 5(3):193-205. DOI: 10.1007/BF01065395. View

18.

BUCHTHAL F, SVENSMARK O, SCHILLER P . Clinical and electroencephalographic correlations with serum levels of diphenylhydanotin. Arch Neurol. 1960; 2:624-30. DOI: 10.1001/archneur.1960.03840120030004. View

19.

Fabre J, Balant L . Renal failure, drug pharmacokinetics and drug action. Clin Pharmacokinet. 1976; 1(2):99-120. DOI: 10.2165/00003088-197601020-00002. View

20.

Alvan G, Borga O, Lind M, Palmer L, Siwers B . First pass hydroxylation of nortriptyline: concentrations of parent drug and major metabolites in plasma. Eur J Clin Pharmacol. 1977; 11(3):219-24. DOI: 10.1007/BF00606414. View